Detection of c-kit mutational status in small-cell lung cancer in a Chinese cohort

Thoracic Cancer
Ying ChengYawen Liu

Abstract

Overexpression of KIT (CD117), a tyrosine kinase receptor, and its natural ligand, stem cell factor, are found in small-cell lung cancer (SCLC). Somatic mutations of the proto-oncogene c-kit constitutively activate KIT expression in a ligand-independent way. To explore the clinical value of the c-kit mutation as a potential target for therapy with tyrosine kinase inhibitors, the c-kit mutational status and KIT expression in tumors from Chinese patients with SCLC were analyzed. Using 107 paraffin-embedded SCLC tumor specimens, c-kit exons 9, 11, 13, and 17 were analyzed for mutations by polymerase chain reaction and direct sequencing. There were no activating mutations in exons 9, 11, 13, or 17. However, a point mutation in intron 16 (81240 G>A) was found in 11 out of the 107 samples (10.3%), of which the majority were limited-stage SCLC (10/11, 90.9%). Immunohistochemical staining of tumors harboring the c-kit point mutation using the anti-CD117 antibody showed that the mutation status was not associated with the expression of KIT. These findings indicate that the incidence and the types of c-kit mutations in SCLC tumors found in Chinese are different from those of the Caucasian population. Nevertheless, c-kit mutations are sim...Continue Reading

References

Mar 26, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H BurgerK Nooter
Mar 24, 2004·Leukemia Research·Martin Sattler, Ravi Salgia
Jun 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Laura BoldriniGabriella Fontanini
Apr 13, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G RostiG Genestreti
Apr 11, 2007·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Ana López-MartinLuis Paz-Ares
Sep 7, 2007·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·David R SpigelUNKNOWN Minnie Pearl Cancer Research Network
Mar 31, 2009·Current Opinion in Cell Biology·Darrin Stuart, William R Sellers
Sep 3, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Soundararajan KrishnaswamyRavi Salgia
Feb 26, 2011·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayDonald Maxwell Parkin
Apr 28, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Philippe BroëtPatrick Tan
May 25, 2011·Journal of Translational Medicine·Alessandra MaledduGuido Biasco
Oct 18, 2011·Clinical Lung Cancer·Laurie E GasparJames A Bonner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

Related Papers

Lung Cancer : Journal of the International Association for the Study of Lung Cancer
Kiyotaka YohNagahiro Saijo
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
H BurgerKees Nooter
© 2022 Meta ULC. All rights reserved